...
首页> 外文期刊>Internal medicine. >Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
【24h】

Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine

机译:在成人发作的贫困病中获得了亚基约核细胞血小板症:与康斯押沙利和环孢菌素的成功联合治疗

获取原文

摘要

Adult-onset Still's disease (AOSD) sometimes demonstrates hematologic disorder, whereas acquired amegakaryocytic thrombocytopenia (AAT) involvement is extremely rare. We herein report a 67-year-old woman with relapse of AOSD who concomitantly developed AAT. Thrombocytopenia along with high disease activity of AOSD was resistant to high-dose prednisolone, even in combination with methotrexate and tacrolimus. However, alternative treatment with cyclosporine after administering tocilizumab resulted in the improvement of thrombocytopenia, ultimately demonstrating that combination therapy based on suppressing the intractable disease activity of AOSD and subsequently adding a reliable immunosuppressant was required to achieve remission.
机译:成人发作仍然是疾病(AOSD)有时会展示血液学疾病,而获得的亚比亚义型血管发育病症(AAT)受累是极为罕见的。我们在此报告了一名67岁的女性,伴随着AOSD的复发,他们伴随着AAT。血小板减少症以及AOSD的高疾病活性耐受高剂量泼尼松龙,甚至与甲氨蝶呤和标准司组合。然而,施用与巯基后的环孢菌素替代处理导致血小板减少症的改善,最终证明基于抑制AOSD的顽固性疾病活性并随后添加可靠免疫抑制剂的联合治疗得到达到缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号